Background Gradient

Phase 1 Clinical Trials

These groundbreaking studies focus on determining the safety, dosage, and side effects of experimental therapies. At Plexus Clinical, our AI-enhanced Phase 1 trials provide unprecedented safety monitoring and personalized dosing protocols.

These groundbreaking studies focus on determining the safety, dosage, and side effects of experimental therapies. At Plexus Clinical, our AI-enhanced Phase 1 trials provide

unprecedented safety monitoring and personalized dosing protocols.

Let's Talk

Phase 1 clinical trials represent the crucial bridge between laboratory research and real-world medical treatment. After years of laboratory testing and animal studies show promising results, Phase 1 trials mark the first time a new treatment is tested in human volunteers. These studies typically involve small groups of participants and are designed with the utmost care for participant safety.

Small Participant Groups
Typically 15-30 participants, allowing for intensive monitoring and personalized attention from our research team.

Safety First Approach
AI-powered 24/7 monitoring systems track every vital sign and response, with immediate alerts for any concerns.

Dose Escalation Studies
Gradual dose increases using machine learning algorithms to find the optimal therapeutic window.
Phase 1 clinical trials represent the crucial bridge between laboratory research and real-world medical treatment. After years of laboratory testing and animal studies show promising results, Phase 1 trials mark the first time a new treatment is tested in human volunteers. These studies typically involve small groups of participants and are designed with the utmost care for participant safety.

Small Participant Groups
Typically 15-30 participants, allowing for intensive monitoring and personalized attention from our research team.

Safety First Approach
AI-powered 24/7 monitoring systems track every vital sign and response, with immediate alerts for any concerns.

Dose Escalation Studies
Gradual dose increases using machine learning algorithms to find the optimal therapeutic window.
Phase 1 clinical trials represent the crucial bridge between laboratory research and real-world medical treatment. After years of laboratory testing and animal studies show promising results, Phase 1 trials mark the first time a new treatment is tested in human volunteers. These studies typically involve small groups of participants and are designed with the utmost care for participant safety.

Small Participant Groups
Typically 15-30 participants, allowing for intensive monitoring and personalized attention from our research team.

Safety First Approach
AI-powered 24/7 monitoring systems track every vital sign and response, with immediate alerts for any concerns.

Dose Escalation Studies
Gradual dose increases using machine learning algorithms to find the optimal therapeutic window.

Primary Goals of Phase 1 Trials

Safety Assessment

Identify and monitor any side effects or adverse reactions. Our AI systems continuously analyze participant responses to detect even subtle changes in health status.


Dosage Determination

Find the maximum tolerated dose (MTD) and recommended Phase 2 dose using predictive algorithms that optimize both safety and efficacy.


Pharmacokinetics Study

Understand how the body processes the treatment - absorption, distribution, metabolism, and elimination patterns.


Early Efficacy Signals

While not the primary goal, we monitor for any early signs that the treatment might be working using advanced biomarker analysis.

Who Can Participate?

Advanced Disease Patients

Individuals with serious conditions who have exhausted standard treatment options and are seeking innovative therapies.


Healthy Volunteers

For certain studies, healthy participants help establish baseline safety data for new treatments.


Specific Criteria Met

Participants must meet strict eligibility criteria including age, health status, and previous treatment history.


Our advanced algorithms analyze your complete medical profile to determine the most suitable Phase 1 trials for your specific condition and circumstances, maximizing both safety and potential benefit.

ARIZONA

Prescott Valley

Kingman

Cottonwood

Sun City

Texas and Michigan sites coming Fall 2025

TEXAS

COMING SOON!

MICHIGAN

COMING SOON!

Our Convenient Locations

Explore our network of accessible locations, purposefully designed to make quality healthcare part of your neighborhood.

Tempe, AZ

1030 E. Guadalupe Rd. #3044, Tempe, AZ 85283

Spring, TX

5220 FM 2920 Suite 501 Spring TX 77388

Prescott Valley, AZ

7900 Florentine Rd. Prescott Valley, AZ 86314

Kingman, AZ

1841 Morrow Ave. Kingman, AZ 86409

Cottonwood

203 S. Candy Ln. Suite 6A Cottonwood, AZ 86326

Sun City, AZ

13949 W. Meeker Blvd. Sun City West, AZ 85375

Tempe, AZ

1030 E. Guadalupe Rd. #3044, Tempe, AZ 85283

Spring, TX

5220 FM 2920 Suite 501 Spring TX 77388

Prescott Valley, AZ

7900 Florentine Rd. Prescott Valley, AZ 86314

Kingman, AZ

1841 Morrow Ave. Kingman, AZ 86409

Cottonwood

203 S. Candy Ln. Suite 6A Cottonwood, AZ 86326

Sun City, AZ

13949 W. Meeker Blvd. Sun City West, AZ 85375

ARIZONA

Prescott Valley

Kingman

Cottonwood

Sun City

Texas and Michigan sites coming Fall 2025

TEXAS

COMING SOON!

MICHIGAN

COMING SOON!

Regulatory Excellence by Design

Regulatory Excellence
by Design

FDA regulations and ICH-GCP guidelines

Institutional Review Board (IRB) oversight

Regular audits and quality assurance procedures

Comphrehensive staff training and certification

Electronic data capture systems for accurate record-keeping

Book Your Appointment Today

Learn How You Can Paricipate Today

Something is taking shape.
Coming soon.

Plexus Clinical